Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. TENX
TENX logo

TENX

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

TENX News

Tenax Therapeutics Q4 Earnings Beat Expectations

1d agoseekingalpha

Tenax Therapeutics (TENX) Price Target Raised by 12.22% to 25.76

Dec 21 2025NASDAQ.COM

Tenax Initiates Global LEVEL-2 Study, Enrollment Expected by 2027

Dec 17 2025Newsfilter

Tenax Initiates Global LEVEL-2 Study, Enrollment Expected by 2027

Dec 17 2025Globenewswire

Tenax Therapeutics: Overview of Q3 Earnings

Nov 12 2025Yahoo Finance

Tenax Therapeutics: Q2 Earnings Snapshot

Aug 13 2025Yahoo Finance

Teanx Therapeutics plans secondary offering

Apr 16 2025SeekingAlpha

Tenax Therapeutics files to sell 4.14M shares of common stock for holders

Apr 15 2025Business Insider

Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Mar 25 2025Newsfilter

Tenax Therapeutics Appoints Interim CFO Thomas McGauley

Dec 04 2024Business Insider

Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors

Nov 04 2024PRnewswire

This Sempra Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Oct 24 2024Benzinga

TENX Stock Earnings: Tenax Therapeutics Beats EPS for Q2 2024

Aug 14 2024Business Insider

Tenax Therapeutics Announces Oversubscribed $100 Million Private Placement

Aug 06 2024Newsfilter

Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Apr 18 2024Business Insider

Why Alcoa Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Apr 18 2024Benzinga